reglab/statecodes huggingface dataset:
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 693 - CONTROL OF SEXUALLY TRANSMISSIBLE INFECTIONS CODE › Section 693.110 - Examination and Treatment of Prisoners

Current through Register Vol. 48, No. 28, July 12, 2024
a A local health department or the Department
			 may enter any State, county or municipal detention facility located within its
			 jurisdiction for the purpose of interviewing, examining, testing or treating
			 any prisoner, detainee or parolee known to have or suspected of having an STI.
			 A detention facility shall cooperate with the local health department or the
			 Department and provide the space necessary for interviewing, examining, testing
			 or treating any prisoner, detainee or parolee known or suspected of having an
			 STI.
b Interviewing, examination,
			 testing or treatment shall be voluntary on the part of the prisoner, detainee
			 or parolee, unless the Department obtains a court-issued warrant pursuant to
			 Section
			 693.50
			 of this Part. In cases of noncompliant behavior, the Department may also seek
			 court-ordered isolation pursuant to Section
			 693.60
			 of this Part.
c Any health care
			 professional attending or examining prisoners, detainees or parolees at
			 detention facilities shall follow the reporting requirements of Section
			 693.30 of this Part,
			 except that reporting to the local health department or Department, where
			 applicable, shall be made within seven days after diagnosing or treating a
			 reportable STI. The superintendent or other administrator of the detention
			 facility shall provide the health care professional with all reportable
			 information required by the report form or this Part to ensure that a complete
			 report is filed with the appropriate health authority.
d Nothing in this Section shall be construed
			 as relieving the Department of Corrections or any county or municipality of
			 their primary responsibility for providing medical services for prisoners under
			 their jurisdiction, including treatment for STIs. (Section 9(b) of the
			 Act)
e Subsections (a) and (b) do
			 not apply to any examination, testing or treatment performed pursuant to
			 Section 5-5-3(g) or (h) of the Unified Code of Corrections. Section 5-5-3 of
			 the Unified Code of Corrections requires HIV testing of defendants convicted
			 under Sections 11-14, 11-15, 11-15.1, 11-16, 11-17, 11-18, 11-18.1, 11-19,
			 11-19.1, 11-19.2, 12-13, 12-14, 12-14.1, 12-15 or 12-16 of the Criminal Code of
			 1961, or Section 1 or 2 of the Hypodermic Syringes and Needles Act.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 693 - CONTROL OF SEXUALLY TRANSMISSIBLE INFECTIONS CODE › Section 693.120 - Certificate of Freedom from STIs

Current through Register Vol. 48, No. 28, July 12, 2024
No health care professional, local health department,
				designated agent or other person, including the Department, shall issue
				certificates of freedom from STIs to or for any person.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 693 - CONTROL OF SEXUALLY TRANSMISSIBLE INFECTIONS CODE › Section 693.130 - Treatment of Minors

Current through Register Vol. 48, No. 28, July 12, 2024
A minor12 years of age or older who may have come into contact
				with any STI may give consent to the furnishing of medical care or counseling
				related to the diagnosis or treatment of, or vaccination against, an STI.
				[410
				ILCS 210/4 ]
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 693 - CONTROL OF SEXUALLY TRANSMISSIBLE INFECTIONS CODE › Section 693.150 - Expedited Partner Therapy (EPT)

Current through Register Vol. 48, No. 28, July 12, 2024
a)
			 Persons with a clinical diagnosis of chlamydia, gonorrhea, or trichomoniasis,
			 preferably confirmed with a laboratory test, are eligible for EPT.
b) Sex partners of patients treated for
			 chlamydia, gonorrhea, or trichomoniasis, who were exposed within the previous
			 60 days and who are unable or unlikely to seek medical care are eligible for
			 EPT. If there were no sex partners within the previous 60 days, the most recent
			 sex partner is eligible.
c)
Health care professionals who provide EPT shall comply with Sections 4
			 and 5 of the Act.
(Section 6(e)(2) of the Act)
d) EPT is not contraindicated but is a last
			 resort for pregnant partners. Health care professionals shall attempt to
			 contact the pregnant partner and ensure that she is referred for medical
			 care.
e)
Health care
			 professionals who provide EPT shall provide counseling for the patient and
			 written materials provided by the Department to be given by the patient to the
			 partner or partners that include, at a minimum, the following:
1)
A warning that a woman who is
			 pregnant or might be pregnant must not take certain antibiotics and must
			 immediately contact a health care professional for an examination, and a
			 recommendation for such an examination;
2)
Information about the antibiotic
			 and dosage provided or prescribed; clear and explicit allergy and side effect
			 warnings, including a warning that a partner who has a history of allergy to
			 the antibiotic or the pharmaceutical class of antibiotic must not take the
			 antibiotic and must be immediately examined by a health care professional, and
			 a recommendation for such an examination;
3)
Information about the treatment
			 and prevention of sexually transmissible
infections;
4)
The requirement of abstinence
			 until a period of time after treatment to prevent infecting
			 others;
5)
Notification of the:
A)
importance of the partner or partners of the patient
receiving
examination and testing for HIV and other sexually
			 transmissible
infections;
and
B)
available
			 resources;
6)
Notification of the risk to self, others, and the public health if the
			 sexually transmissible
infection
is not completely and
			 successfully treated;
7)
The responsibility of the partner or partners to inform his or her sex
			 partner or partners of the risk of sexually transmissible
infection
and the importance of prompt examination and treatment.
(Section 6(e)(3) of the Act)
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 694 - COLLEGE IMMUNIZATION CODE › Subpart A - GENERAL PROVISIONS › Section 694.30 - Referenced Materials

Current through Register Vol. 48, No. 28, July 12, 2024
The following materials are referenced in this Part:
a) Nurse Practice Act [225 ILCS 65
				]
b) Pharmacy Practice Act [225
				ILCS 85 ]
c) Physician Assistant
				Practice Act of 1987 [225 ILCS 95 ]
d) Family Educational Rights and Privacy Act
				of 1974 ( 20 USC
				1232g) and
				34
				CFR 99.36.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 694 - COLLEGE IMMUNIZATION CODE › Subpart B - IMMUNIZATION REQUIREMENTS › Section 694.100 - Proof of Immunity

Current through Register Vol. 48, No. 28, July 12, 2024
a)
				Beginning with the Fall term 2016-2017, students who enroll at a post-secondary
				educational institution shall present to the designated recordkeeping office
				proof of immunity evidencing the following immunizations:
1) Diphtheria, Tetanus, Pertussis
A) Students shall provide dates of any
				combination of three or more doses of Diphtheria, Tetanus, and Pertussis
				containing vaccine. One dose must be Tdap vaccine. The last dose of vaccine
				(DTP, DTaP, DT, Td, or Tdap) must have been received within 10 years prior to
				the term of current enrollment.
B)
				The minimum time interval between the first and second dose must have been at
				least four weeks (28 days), with the third dose having been received at least
				six months after the second or last dose of the basic series.
C) Receipt of Tetanus Toxoid (T.T.) vaccine
				is not acceptable in fulfilling this requirement.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 694 - COLLEGE IMMUNIZATION CODE › Subpart B - IMMUNIZATION REQUIREMENTS › Section 694.110 - Record Keeping

Current through Register Vol. 48, No. 28, July 12, 2024
a) The
				designated recordkeeping office shall maintain records containing the required
				elements (as in Appendix C) of the immunization status of each student. The
				student health records shall be maintained by the post-secondary educational
				institution.
b) If an exemption has
				been granted for medical or religious reasons, or if laboratory evidence of
				immunity has been submitted, a copy of the request for exemption or the
				laboratory report must be kept with the student health record.
c) A post-secondary educational institution
				shall keep susceptibility lists by disease category indicating the names of all
				students who are granted medical or religious exemptions by the institution or
				who have not provided proof of immunity. Those lists shall be disclosed to the
				Department in health and safety emergencies in accordance with the Family
				Educational Rights and Privacy Act of 1974 (
				20 USC
				1232g) and
				34
				CFR 99.36.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 694 - COLLEGE IMMUNIZATION CODE › Subpart B - IMMUNIZATION REQUIREMENTS › Section 694.120 - Completion and Submission of the Summary Report

Current through Register Vol. 48, No. 28, July 12, 2024
a) Each post-secondary educational
				institution shall submit an annual summary report on forms provided by the
				Department to the Department within eight weeks after commencement of the fall
				term of the academic year.
b) The
				summary report shall be signed by an official of the designated record keeping
				office certifying that the information provided is correct.
c) In order to determine compliance with this
				Part, the Department or its designated representative may audit student health
				records, as they relate to certification of immunity, from which personal
				identifiable information has been deleted in accordance with the Family
				Educational Rights and Privacy Act of 1974 (
				20
				U.S.C. 1232 g ) and
				34
				CFR 99.36.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 694 - COLLEGE IMMUNIZATION CODE › Subpart C - EXEMPTIONS › Section 694.200 - Medical Exemption

Current through Register Vol. 48, No. 28, July 12, 2024
a) A
				student may be exempted from one or more of the specific immunization
				requirements specified in this Part upon acceptance by the designated record
				keeping office of a written statement by a physician indicating the nature and
				probable duration of the medical condition or circumstances that
				contraindicates those immunizations, identifying the specific vaccines that
				could be detrimental to the student's health.
b) Female students may be granted temporary
				exemption from immunization against measles, mumps, and rubella under
				subsection (a) if pregnancy or suspected pregnancy is certified by a written
				physician's statement.
c) If a
				student is on an approved schedule of receipt for any required vaccine, the
				student will be granted temporary medical exemption for the duration of the
				approved schedule.
d) If a
				student's medical condition or circumstances later permit immunization, the
				exemptions granted under subsection (a), (b) or (c) shall terminate and the
				student shall be required to obtain the immunizations from which the student
				has been exempted.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 694 - COLLEGE IMMUNIZATION CODE › Subpart C - EXEMPTIONS › Section 694.210 - Religious Exemption

Current through Register Vol. 48, No. 28, July 12, 2024
A student may be exempted from the immunization requirements
				  specified in this Part upon acceptance by the designated recordkeeping office
				  of a written and signed statement by the student (or the student's parent or
				  guardian, if the student is a minor) detailing the student's objection to
				  immunization on religious grounds. The objection must set forth the specific
				  religious belief that conflicts with the immunization. The religious objection
				  may be personal and need not be directed by the tenets of an established
				  religious organization. General philosophical or moral reluctance to allow
				  immunizations will not provide a sufficient basis for an exception to statutory
				  requirements.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 694 - COLLEGE IMMUNIZATION CODE › Subpart C - EXEMPTIONS › Section 694.220 - Classification Exemption

Current through Register Vol. 48, No. 28, July 12, 2024
Students are exempt from the immunization requirements of
				  this Part if they are enrolled for:
a)
				Less than half-time during a term, semester, quarter; or
b) Instruction solely involving research,
				field work, or study outside of a classroom environment; or
c) Instruction that utilizes correspondence
				as its primary mode of delivery. This includes students who are only enrolled
				in courses where no direct (physical) interaction occurs between the student
				and others receiving similar instruction (e.g., telecourses, courses by way of
				mail).
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 694 - COLLEGE IMMUNIZATION CODE › Subpart C - EXEMPTIONS › Appendix C - Required Elements of Health Record

Current through Register Vol. 48, No. 28, July 12, 2024
1. Name
2. Student Identification Number
3. Month, Day and Year of Birth
4. Gender
5. Term and Year of First Entry
6. Dates to Establish Immunity to Measles (Rubeola)
7. Dates to Establish Immunity to Rubella
8. Dates to Establish Immunity to Mumps
9. Dates to Establish Immunity to Tetanus/Diphtheria
10. Date of Most Recent Tetanus/Diphtheria/Pertussis Booster
				  (Tdap)
11. Date of Most Recent Meningococcal Vaccine
12. Phone Number of Certifying Health Care Provider
13. Name and Signature of Health Care Provider
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 695 - IMMUNIZATION CODE (Repealed) › Appendix A - Vaccination Schedule for Haemophilus influenzae type b Conjugate Vaccines (Hib) (Repealed)

Current through Register Vol. 48, No. 28, July 12, 2024
A DTP/Hib combination vaccine can be used in place of HbOC or
				  PRP-T
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 696 - CONTROL OF TUBERCULOSIS CODE › Subpart A - GENERAL PROVISIONS › Section 696.110 - Incorporated and Referenced Materials

Current through Register Vol. 48, No. 28, July 12, 2024
a) The following materials are incorporated
				by reference in this Part:
1) Prevention and
				Control of Tuberculosis in Correctional and Detention Facilities:
				Recommendations from CDC, U.S. Department of Health and Human Services,
				Coordinating Center for Health Information and Service, Centers for Disease
				Control and Prevention, 1600 Clifton Rd., Atlanta GA 30333 (Morbidity and
				Mortality Weekly Report (MMWR), July 7, 2006; 55 (No. RR9):1-44).
2) Guidelines for Preventing the Transmission
				of Mycobacterium Tuberculosis in Health-Care Settings, 2005 (referred to as
				"Guidelines for Health-Care Settings"), U.S. Department of Health and Human
				Services, Coordinating Center for Health Information and Service, Centers for
				Disease Control and Prevention, 1600 Clifton Rd., Atlanta GA 30333 (Morbidity
				and Mortality Weekly Report (MMWR), December 30, 2005; 54 (No.
				RR17):1-141).
3) Targeted
				Tuberculin Testing and Treatment of Latent Tuberculosis Infection, U.S.
				Department of Health and Human Services, Centers for Disease Control and
				Prevention, 1600 Clifton Rd., Atlanta GA 30333 (Morbidity and Mortality Weekly
				Report (MMWR), June 9, 2000; 49 (No. RR-6)).
4) Treatment of Tuberculosis, U.S. Department
				of Health and Human Services, Centers for Disease Control and Prevention, 1600
				Clifton Rd., Atlanta GA 30333 (Morbidity and Mortality Weekly Report (MMWR),
				June 20, 2003; 52 (No. RR-11)).
5)
				Guidelines for the Investigation of Contacts of Persons with Infectious
				Tuberculosis: Recommendations from the National Tuberculosis Association and
				CDC (referred to as "Guidelines for Investigation of Contacts"), U.S.
				Department of Health and Human Services, Coordinating Center for Health
				Information and Service, Centers for Disease Control and Prevention, 1600
				Clifton Rd., Atlanta GA 30333 (Morbidity and Mortality Weekly Report (MMWR),
				December 16, 2005; 54 (No. RR15):1-47).
6) Privacy Rule (Standards for Privacy of
				Individually Identifiable Health Information) of the Health Insurance
				Portability and Accountability Act of 1996 and
				45
				CFR 164.512(a) and (k)(6)
				(October 1, 2007).
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 696 - CONTROL OF TUBERCULOSIS CODE › Subpart B - TUBERCULOSIS PREVENTION AND CONTROL MEASURES › Section 696.150 - Management of Persons with Latent Tuberculosis Infection (LTBI)

Current through Register Vol. 48, No. 28, July 12, 2024
a) Treatment for
				LTBI. Persons with a positive TB screening test result shall complete a
				diagnostic evaluation for active TB disease. If there is no evidence of active
				TB disease, persons with LTBI shall be considered for treatment. Treatment for
				LTBI shall be conducted in accordance with the CDC guidelines Targeted
				Tuberculin Testing and Treatment of Latent TB Infection.
b) Monitoring for Adverse Medication
				Reaction. At a minimum, patients shall be monitored monthly during therapy and
				evaluated for adverse medication reactions.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 696 - CONTROL OF TUBERCULOSIS CODE › Subpart B - TUBERCULOSIS PREVENTION AND CONTROL MEASURES › Section 696.160 - Diagnosis and Management of Persons with Suspected or Confirmed Active Tuberculosis Disease

Current through Register Vol. 48, No. 28, July 12, 2024
a)
				Diagnostic Evaluation. The evaluation of persons with suspected or confirmed
				active TB disease shall include but not be limited to:
1) Medical history;
2) Physical examination;
3) TB screening test;
4) Chest radiograph;
5) Bacteriologic examinations on available
				specimens; and
6) Assessment of
				risk for HIV infection, and testing and counseling as indicated.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 696 - CONTROL OF TUBERCULOSIS CODE › Subpart C - ENFORCEMENT OF TUBERCULOSIS PREVENTION AND CONTROL MEASURES › Section 696.180 - Role of the Department or Local TB Control Authority in Enforcement and Control

Current through Register Vol. 48, No. 28, July 12, 2024
The Department or local TB control authority may issue
				  directives, seek court orders or issue emergency orders as necessary to protect
				  the public health, safety and welfare.
a) Directives. When necessary to protect the
				public health, safety and welfare, the Department or local TB control authority
				may ensure prevention and control measures by issuing Department or local TB
				control authority directives. A directive is a letter that informs recipients
				what is required of them to be in compliance with this Part and the
				consequences of noncompliance.
b)
				The Department or local TB control authority shall implement matters of
				quarantine, isolation and closure in accordance with 77 Ill. Adm. Code 690.
				Subpart H.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 697 - HIV/AIDS CONFIDENTIALITY AND TESTING CODE › Subpart A - GENERAL PROVISIONS › Section 697.30 - Incorporated and Referenced Materials

Current through Register Vol. 48, No. 28, July 12, 2024
a) The following materials are referenced in
				this Part:
1) Illinois Statutes
A) AIDS Confidentiality Act [ 410 ILCS 305
				]
B) AIDS Registry Act [ 410 ILCS
				310 ]
C) Unified Code of
				Corrections [ 730 ILCS 5 ]
D)
				Medical Patient Rights Act [ 410 ILCS 50 ]
E) Perinatal HIV Prevention Act [ 410 ILCS
				335 ]
F) Civil Administrative Code
				of Illinois [ 20 ILCS 2310/55 to 55.45].
G) Abused and Neglected Child Reporting Act [
				325 ILCS 5 ]
H) Illinois Insurance
				Code [ 215 ILCS 5 ]
I) Consent by
				Minors to Medical Procedures Act [ 410 ILCS 210 ]
J) Illinois Sexually Transmissible Disease
				Control Act [ 410 ILCS 325 ]
K)
				Medical Practice Act of 1987 [ 225 ILCS 60 ]
L) Perinatal HIV Prevention Act [ 410 ILCS
				335 ]
M) Criminal Code of 2012 [
				720 ILCS 5 ]
N) Code of Civil
				Procedure [ 735 ILCS 5 ]
O)
				Illinois Anatomical Gift Act [ 755 ILCS 50 ]
P) Organ Donation Request Act [ 755 ILCS 60
				]
Q) Illinois Finance Authority Act
				[ 20 ILCS 3501 ]
R) Illinois Health
				Information Exchange and Technology Act [ 20 ILCS 3860 ]
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 697 - HIV/AIDS CONFIDENTIALITY AND TESTING CODE › Subpart A - GENERAL PROVISIONS › Section 697.40 - Administrative Hearings

Current through Register Vol. 48, No. 28, July 12, 2024
Any administrative hearings conducted by the Department
				  concerning this Part shall be governed by the Department's Practice and
				  Procedure in Administrative Hearings.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 697 - HIV/AIDS CONFIDENTIALITY AND TESTING CODE › Subpart B - HIV TESTING › Section 697.100 - Approved HIV Tests and Testing Procedures

Current through Register Vol. 48, No. 28, July 12, 2024
a Any person, laboratory, blood bank,
				hospital or other entity that conducts laboratory tests to detect the presence
				of HIV infection shall use an approved HIV test as defined in this Part. (See
				Section
				697.20.)
1 Supplemental testing shall be completed
				before HIV test results are released to the health care professional or other
				individuals authorized to receive the results as described and limited in
				Section
				697.140,
				except in the following situations:
A When
				immediate medical treatment is necessary to prevent further transmission of HIV
				to a newborn infant in labor, delivery and postpartum settings. For the
				purposes of this subsection (a)(1), immediate medical treatment, for a newborn
				infant, means upon delivery or within 48 hours after the infant's birth.
				(Section 10 of the Perinatal HIV Prevention Act) Treatment shall be conducted
				as provided by the Recommendations for Use of Antiretroviral Drugs in Pregnant
				HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal
				HIV Transmission in the United States (see Section
				697.30
				);
B In instances of occupational
				exposure, as provided by Section
				697.140(a)(8)
				and (9); or
C At the time of testing, provided that the
				subject of the test or the subject's legally authorized representative has
				received pre-test information, has been informed of his/her right to refuse
				testing, and has provided consent to be tested and to receive a preliminary
				test result in accordance with Sections
				697.110
				and
				697.120, except
				in the case of a newborn infant as provided in the Perinatal HIV Prevention
				Act.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 697 - HIV/AIDS CONFIDENTIALITY AND TESTING CODE › Subpart B - HIV TESTING › Section 697.110 - HIV Pre-Test Information

Current through Register Vol. 48, No. 28, July 12, 2024
a) No
				health care professional may order an HIV test without making available to the
				person tested pre-test information.
Pre-test information may be
				provided in writing, verbally, or by video, electronic, or other means and may
				be provided as designated by the supervising health care professional or health
				facility.
(Section 3(w-5) of the Act) The subject must be offered an
				opportunity to ask questions about the HIV test, or to decline
				testing.
b) Pre-test information
				may be included along with other medical information generally provided to a
				subject. The required pre-test information consists of the following
				information:
1)
A reasonable
				explanation of the test, including its purpose, potential use, limitations, and
				the meaning of the results;
2)
A reasonable explanation of the
				procedures to be followed, including the voluntary nature of the
				test;
3)
The
				availability of a qualified person to answer questions;
4)
The right to withdraw consent to
				the test process at any time;
5)
The right to anonymity, to the
				extent provided by law, with respect to participation in the test and
				disclosure of test results
;
6)
The right to confidential
				treatment of information identifying the subject of the test and the results of
				the test, to the extent provided by law
(Section 3(w-5) of the Act);
				and
7) The availability of
				referrals for further information or counseling.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 697 - HIV/AIDS CONFIDENTIALITY AND TESTING CODE › Subpart B - HIV TESTING › Section 697.120 - Informed Consent

Current through Register Vol. 48, No. 28, July 12, 2024
a)
No person may order an HIV test without first providing pre-test
				information and receiving the
documented
informed consent of
				the subject of the test or the subject's legally authorized
				representative
, except as provided in subsection (b). (Section 4 of
				the Act)
1)
A health care provider,
				health care professional, or health care facility undertaking an informed
				consent process for HIV testing may combine a form used to obtain informed
				consent for HIV testing with forms used to obtain written consent for general
				medical care or any other medical test or procedure, provided that the forms
				make it clear that the subject may consent to general medical care, tests, or
				procedures without being required to consent to HIV testing, and clearly
				explain how the subject may decline HIV testing
.
Health
				facility clerical staff or other staff members may obtain consent for HIV
				testing through a general consent form.
(Section 3(q) of the
				Act)
2)
A health care
				provider, health care professional, or health care facility conducting opt-in
				testing and obtaining informed consent shall document verbal or written consent
				in the general consent for medical care, a separate consent form, or elsewhere
				in the medical record.
3)
A health care provider, health care professional, or health care
				facility conducting opt-out testing shall document the subject's or the
				subject's legally authorized representative's declination of the test in the
				medical record. Individual documentation of the provision of pre-test
				information to each test subject is not required. A health care provider,
				health care professional, or health care facility conducting opt-out testing
				shall establish and implement a written procedure for conducting opt-out
				testing and for providing pre-test information.
(Section 4 of the
				Act)
4) When
the person
				providing informed consent is a participant in an HIE, informed consent
				requires a fair explanation that the results of the patient's HIV test will be
				accessible through an HIE and meaningful disclosure of the patient's opt-out
				right.
(Section 3(q) of the Act)
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 697 - HIV/AIDS CONFIDENTIALITY AND TESTING CODE › Subpart B - HIV TESTING › Section 697.130 - Anonymous Testing

Current through Register Vol. 48, No. 28, July 12, 2024
Any individual seeking an HIV test shall have the right to
				  anonymous testing, unless identification of the test subject is otherwise
				  required. Anonymous testing shall be performed after pre-test information is
				  provided and informed consent is obtained, using a coded system that does not
				  link individual identity with the request or result. A health care facility or
				  health care professional that does not provide anonymous testing shall refer an
				  individual requesting an anonymous test to a site where it is available.
				  (Section 6 of the Act) Any anonymous testing system adopted by the health care
				  professional ordering the test shall ensure that the persons conducting the
				  laboratory tests transmit the correct test results to the proper health care
				  professional, and that the correct test results are given to the correct
				  patient. When a test subject does not have the right to request anonymity, the
				  test subject may request that the blood sample be labeled so as to prevent any
				  person from learning the identity of the test subject, unless the person is
				  authorized to receive the information pursuant to Section
				  697.140
				  of this Part.
a) If anonymous testing
				is requested, the health care professional shall assign to the person a unique
				number or notation, which shall be used in lieu of the person's name. The
				specimen for testing shall be labeled with the name of the health care
				professional or health care facility and the unique number or notation assigned
				to the patient for the purpose of receiving the test results. Unless otherwise
				authorized by the patient, any record of the test result shall be maintained in
				a manner identifying the record only by its unique number or
				notation.
b) Anonymous testing
				shall not be permitted under the following circumstances:
1) When identification of the test subject is
				permitted or required to comply with Section
				697.140(a)(3)
				or (6) of this Part; or
2) If the test is performed to determine
				eligibility as a donor or acceptability of a donation of blood, plasma, semen,
				oocytes or other human tissue.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 697 - HIV/AIDS CONFIDENTIALITY AND TESTING CODE › Subpart B - HIV TESTING › Section 697.155 - Delivery of HIV Test Results

Current through Register Vol. 48, No. 28, July 12, 2024
a)
				The subject of the test or the subject's legally authorized representative
				shall be notified in person whenever possible of the confirmed positive result
				of an HIV test. (Section 9.5(b) of the Act) If the results are provided over
				the phone, the health care professional shall ensure that results are delivered
				to the test subject or the legally authorized representative only through
				methods such as verifying the subject's date of birth or other confidential
				information known only to the subject.
1) A
				health care professional shall make at least two attempts to deliver a positive
				test result to the subject or the subject's legally authorized
				representative.
2) If a health care
				professional is unable to notify a subject or the subject's legally authorized
				representative of a positive test within 14 days after receipt of the test
				result, the health care professional shall notify the local health department
				within 21 days after receipt of the test result. The name of the subject
				(unless testing was anonymous) and his or her locating information shall be
				included in the notification.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 697 - HIV/AIDS CONFIDENTIALITY AND TESTING CODE › Subpart B - HIV TESTING › Section 697.160 - HIV Testing for Insurance Purposes

Current through Register Vol. 48, No. 28, July 12, 2024
a) Health maintenance organizations,
				insurance companies, fraternal benefit societies, health services corporations
				and other insurers subject to regulation under the Illinois Insurance Code are
				not required to comply with Sections
				697.110,
				697.120,
				697.130 and
				697.140
				in establishing eligibility and coverage requirements that include mandatory
				HIV tests. This exemption also extends to the physician or other health care
				professional that performs the tests.
b) Health maintenance organizations,
				insurance companies, fraternal benefit societies, health services corporations
				and other insurers subject to the Illinois Insurance Code that require any
				insured patient or applicant for new or continued insurance or coverage to be
				tested for HIV shall:
1) Give the patient or
				applicant prior written notice of such requirement;
2) Proceed with such testing only upon the
				written authorization of the applicant or patient; and
3) Keep the results of such testing
				confidential.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 697 - HIV/AIDS CONFIDENTIALITY AND TESTING CODE › Subpart B - HIV TESTING › Section 697.170 - Enforcement of the AIDS Confidentiality Act

Current through Register Vol. 48, No. 28, July 12, 2024
a) All health care facilities and health care
				professionals are required to comply with this Part. Any failure to comply will
				be addressed in accordance with the following:
1) Health care facilities and health care
				professionals that are licensed, certified, permitted or given any other form
				of recognition by the Department shall comply with the provisions of Sections
				697.110,
				697.120,
				697.130 and
				697.140
				of this Part that are applicable to the health care facilities and health care
				professionals as a condition of licensure, certification, permit or any other
				form of recognition by the Department. The reckless, deliberate or conscious
				failure to comply with these provisions shall constitute grounds for
				suspension, revocation or denial in accordance with the respective licensure,
				certification, permit and other recognition laws and regulations.
2) The Department shall forward to the
				appropriate State, federal or local regulatory agency any complaint that it
				receives concerning the failure by any health care facility or health care
				professional that is subject to regulation by that agency to comply with the
				applicable provisions of Sections 697.110, 697.120, 697.130 and
				697.140.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 697 - HIV/AIDS CONFIDENTIALITY AND TESTING CODE › Subpart B - HIV TESTING › Section 697.180 - HIV Testing for Blood and Human Tissue Donations

Current through Register Vol. 48, No. 28, July 12, 2024
All potential donors of blood, plasma, semen, oocytes,
				  organs, or other tissues shall be tested for HIV infection to determine whether
				  the donated blood, plasma, semen, oocytes, organs, or other human tissue may be
				  infected with HIV.
a) All potential
				donors shall receive the HIV pre-test information set forth in Section
				697.110(a)
				of this Part and be given the opportunity to refuse HIV testing. The informed
				consent provisions of Section
				697.120 of this
				Part are required.
b) If HIV
				testing is refused, the person shall not be accepted as a donor.
c) The results of HIV testing shall be
				delivered in accordance with Section
				697.155
				and 77 Ill. Adm. Code 450 and 470.
d) The results of HIV testing shall be kept
				confidential in accordance with Section
				697.140.
e) The donated blood, plasma, semen, oocytes,
				organs or other human tissue shall be handled in accordance with 77 Ill. Adm.
				Code 450 and 470.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 697 - HIV/AIDS CONFIDENTIALITY AND TESTING CODE › Subpart C - HIV/AIDS REGISTRY SYSTEM › Section 697.200 - HIV/AIDS Registry System

Current through Register Vol. 48, No. 28, July 12, 2024
The Department's HIV/AIDS Registry System has been created to
				  compile more complete and precise statistical data than is presently available
				  in order to evaluate HIV treatment and prevention measures. The HIV/AIDS
				  Registry System is a compilation of information concerning reported cases of
				  AIDS and HIV.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 697 - HIV/AIDS CONFIDENTIALITY AND TESTING CODE › Subpart C - HIV/AIDS REGISTRY SYSTEM › Section 697.210 - Reporting Requirements

Current through Register Vol. 48, No. 28, July 12, 2024
a)
				Local health authorities that receive HIV/AIDS reports from health care
				professionals, hospitals or laboratories shall report to the Department's
				HIV/AIDS Registry System within seven days after receiving the HIV/AIDS
				report.
b) The Department requests,
				but does not require, hospitals, clinics, military facilities and prisons
				maintained by the federal government or other governmental agencies within the
				United States to report HIV/AIDS case information concerning present or past
				residents of Illinois, using the Adult HIV/AIDS Confidential Case Report, as
				modified by the Department.
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 697 - HIV/AIDS CONFIDENTIALITY AND TESTING CODE › Subpart C - HIV/AIDS REGISTRY SYSTEM › Section 697.220 - Release of HIV/AIDS Registry Data

Current through Register Vol. 48, No. 28, July 12, 2024
a)
The Department may not
				release
data
gathered pursuant to
the
HIV/AIDS Registry Act
unless
:
1)
It is in a
				statistical
form
that does not identify the
				reporting entity, physician and patient in any way, including by
				address
;
2)
The
				release or transfer is to an Illinois Local Public Health Department or to a
				registry or health department of another state, and is of
data
concerning a person who is residing in that jurisdiction
. The
				Department shall disclose individual patient data concerning residents of
				another state to the Registry in the individual's state of residence if the
				recipient of reported information about HIV/AIDS is legally required to hold
				reported information about HIV/AIDS in confidence and provides protection from
				disclosure of patient identifying information equivalent to the protection
				afforded by the Illinois law. (Section 7(a) of the AIDS Registry Act)
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 697 - HIV/AIDS CONFIDENTIALITY AND TESTING CODE › Subpart E - MISCELLANEOUS PROVISIONS › Section 697.420 - Testing, Treatment or Counseling of Minors

Current through Register Vol. 48, No. 28, July 12, 2024
Any person 12years of age or older who may have come in
				  contact with any STI may consent to testing and to medical care and/or
				  counseling related to the diagnosis and/or treatment of such STI. (Section 4 of
				  the Consent by Minors to Medical Procedure Act)
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 698 - PERTUSSIS VACCINE PAMPHLET CODE › Section 698.20 - Definitions

Current through Register Vol. 48, No. 28, July 12, 2024
"Act" means the Pertussis Vaccine Act (Ill. Rev. Stat. 1987,
				ch. 111 1/2, par. 7501 et seq.).
"Department" means the Department of Public Health. (Section 2
				(b) of the Act.)
"Director" means the Director of Public Health. (Section 2 (a)
				of the Act.)
"Health Care Provider" means any licensed health care
				professional or public or private health care facility in this state that
				administers pertussis vaccine including local health authorities and designated
				agencies. (Section 2 (c) of the Act.)
"Major Adverse Reaction" means collapse or shock, high pitched
				screaming, persistent crying for three or more hours, excessive somnolence
				(sleepiness), temperature of 103 degrees, convulsions with or without
				accompanying fever or severe alterations of consciousness or any serious
				illness, disability or impairment of mental, emotional, behavioral or physical
				functioning or development, the first manifestation of which appears within 30
				days of the date of administration of pertussis vaccine, and for which there is
				reasonable scientific or medical evidence that pertussis vaccine causes or
				significantly contributes to the illness, disability or impairment. (Section 2
				(d) of the Act.)
"Pertussis Vaccine" means any vaccine containing a substance
				intended to prevent the occurrence of pertussis, which adminstered separately
				or in conjunction with other substances intended to prevent the occurence of
				other diseases. (Section 2 (e) of the Act.)
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 698 - PERTUSSIS VACCINE PAMPHLET CODE › Section 698.30 - Pertussis Vaccine Pamphlet

Current through Register Vol. 48, No. 28, July 12, 2024
The Director shall prepare and make available upon request to
				all health care providers, parents and guardians in the State, a pamphlet which
				explains the benefits and possible adverse reactions to immunizations for
				pertussis. This pamphlet is attached as Appendix A Pertussis Vaccine Pamphlet.
				(Section 3 of the Act)
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 698 - PERTUSSIS VACCINE PAMPHLET CODE › Section 698.40 - Health Record - Recording and Reporting

Current through Register Vol. 48, No. 28, July 12, 2024
All health care providers which administer pertussis vaccine
				shall maintain records of the administration of pertussis vaccine and reactions
				to the vaccine in the following manner:
a) Upon administering a pertussis vaccine to
			 a child in this State, a health care provider shall record and retain as part
			 of the child's permanent health record the following information:
1) The date the vaccine was
			 administered,
2) The manufacturer
			 of the vaccine administered,
3) A
			 lot number and any other available identifying information of the vaccine that
			 was administered, and
4) The name,
			 address, telephone number, and title of the health care provider who
			 administered the vaccine. (Section 7 of the Act.)
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 698 - PERTUSSIS VACCINE PAMPHLET CODE › Section 698.50 - School Admission - Immunizations

Current through Register Vol. 48, No. 28, July 12, 2024
A child shall not be required to receive a pertussis vaccine as
				a condition for admission to a public or private school if the child's health
				care provider states in writing that the vaccine is medically contraindicated
				pursuant to subsection (b)(1) of Section 3 of the Act and the reasons for the
				medical contradictions, or if his parent or guardian has submitted a signed
				statement to school officials stating an objection to the vaccination on
				religious grounds. (Section 6 of the Act.)
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 698 - PERTUSSIS VACCINE PAMPHLET CODE › Section 698.60 - Liability

Current through Register Vol. 48, No. 28, July 12, 2024
No physician, hospital nurse or other health care provider
				shall be liable, no cause of action shall be filed, no new cause of action
				shall be created, for any action of failure to act required by or in connection
				with Section 4 of the Act. (Section 5 of the Act.)
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 698 - PERTUSSIS VACCINE PAMPHLET CODE › Section 698.70 - Distribution of Pamphlet By Hospitals

Current through Register Vol. 48, No. 28, July 12, 2024
Every hospital in this State licensed under the Hospital
				Licensing Act (Ill. Rev. Stat. 1987, ch. 1111/2, par. 142 et seq.) or "An Act
				in relation to the founding and operation of the University of Illinois
				Hospital and the conduct of University of Illinois Health Care Programs" (Ill.
				Rev. Stat. 1987, ch. 23, pars. 1371 et seq.), shall provide the parents or
				guardians of each newborn child the pamphlet pursuant to Section 3 of the Act.
				(Section 4 of the Act.)
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 699 - PERINATAL HIV PREVENTION CODE › Subpart A - GENERAL PROVISIONS › Section 699.30 - Referenced Materials

Current through Register Vol. 48, No. 28, July 12, 2024
The following materials are referenced in this Part:
a) Illinois Statutes
1) AIDS Confidentiality Act [410 ILCS 305
				]
2) Perinatal HIV Prevention Act
				[410 ILCS 355 ]
3) Medical Practice
				Act of 1987 [225 ILCS 60 ]
4) Civil
				Administrative Code of Illinois [20 ILCS 2310 ]
5) Consent by Minors to Medical Procedures
				Act [410 ILCS 210 ]
Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 699 - PERINATAL HIV PREVENTION CODE › Subpart B - HIV PERINATAL COUNSELING AND TESTING › Section 699.100 - Perinatal Counseling and Testing

Current through Register Vol. 48, No. 28, July 12, 2024
a) Every health care professional who
				provides health care services to a pregnant woman shall, unless she has already
				been tested during the current pregnancy, provide the woman with HIV
				counseling, as described in this Section, and shall test her for HIV as early
				in the pregnancy as possible, unless she refuses. (Section 10(a) of the
				Act)
b) For women at continued risk
				of exposure to HIV infection in the judgment of the health care professional, a
				repeat test should be recommended late in pregnancy or at the time of labor and
				delivery. (Section 10(a) of the Act)
c) HIV counseling and testing or refusal of
				testing shall be documented in the woman's medical record. (Section 10(b) of
				the Act)
d) Any testing or test
				results shall be conducted in accordance with the AIDS Confidentiality Act and
				the HIV/AIDS Confidentiality and Testing Code and shall bedocumented in
				accordance with the AIDS Confidentiality Act and the HIV/AIDS Confidentiality
				and Testing Code in the woman's medical record. (Section 10(b) of the
				Act)
e) All HIV counseling must be
				provided in accordance with the AIDS Confidentiality Act and must include, at
				minimum, the following information:
1) For
				the health of the pregnant woman, the voluntary nature of the testing, the
				benefits of HIV testing, including the prevention of transmission, and the
				requirement that the HIV testing be performed unless she refuses and the
				methods by which she can refuse;
2)
				The benefit of HIV testing for herself and the newborn infant, including
				interventions to prevent HIV transmission;
3) The side effects of interventions to
				prevent HIV transmission;
4) The
				statutory confidentiality provisions that relate to HIV and AIDS
				testing;
5) The requirement for
				mandatory testing of the newborn if the mother's HIV status is unknown at the
				time of delivery;
6) An explanation
				of the test, including its purpose, limitations, and the meaning of its
				results;
7) An explanation of the
				procedures to be followed;
8) The
				availability of additional or confirmatory testing, if appropriate. Counseling
				may be provided in writing, verbally, or by video, electronic, or other means.
				The woman must be offered an opportunity to ask questions about testing and to
				decline testing for herself. (Section 10(d) of the Act)